[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

DelveInsight: Market Research Reports

DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:

  • Company’s profile and licensing data;
  • New technology studies;
  • Biologic benchmarking;
  • Treatment modality analysis;
  • Competitive landscape;
  • Product assessment; etc.


This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.

DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.

Publications found: 6,889
Sort by:

Cluster Headache Syndrome - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Cluster Headache Syndrome The report also ...

January 2020 60 pages

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Insight, 2020

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Cognitive Impairment Associated With Schizophrenia (CIAS) The report also ...

January 2020 60 pages

Community Acquired Pneumonia - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Community Acquired Pneumonia The report also ...

January 2020 60 pages

Condyloma - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Condyloma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Condyloma development. The report provides detailed ...

January 2020 60 pages

Congenital Heart Disease - Pipeline Insight, 2020

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Congenital Heart Disease The report also ...

January 2020 60 pages

Constipation - Pipeline Insight, 2020

US$ 2,000.00

... clients within 5 Days 'Constipation - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Constipation development. The report provides detailed ...

January 2020 60 pages

Contact Dermatitis - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Contact Dermatitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Contact Dermatitis development. The report provides ...

January 2020 90 pages

Contraceptives - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Contraceptives - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Contraceptives development. The report provides detailed ...

January 2020 90 pages

Corneal Graft Rejection - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Corneal Graft Rejection The report also ...

January 2020 60 pages

Coronary Artery Disease (CAD) - Pipeline Insight, 2020

US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Coronary Artery Disease (CAD) The report also ...

January 2020 90 pages

Cystitis - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Cystitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cystitis development. The report provides detailed ...

January 2020 60 pages

Deep Vein Thrombosis (DVT) - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Deep Vein Thrombosis (DVT) The report also ...

January 2020 60 pages

Degenerative Disc Disease - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Degenerative Disc Disease The report also ...

January 2020 60 pages

Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Dementia Associated With Alzheimer's Disease The report also ...

January 2020 60 pages

Dengue - Pipeline Insight, 2020

US$ 1,500.00

... clients within 72 Hours 'Dengue - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Dengue development. The report provides detailed ...

January 2020 60 pages

Diabetic Nephropathy - Pipeline Insight, 2020

US$ 2,000.00

... clients within 5 Days 'Diabetic Nephropathy - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Diabetic Nephropathy development. The report provides ...

January 2020 60 pages

Diabetic Neuropathic Pain - Pipeline Insight, 2020

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Diabetic Neuropathic Pain The report also ...

January 2020 60 pages

Diabetic Peripheral Neuropathy - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Diabetic Peripheral Neuropathy The report also ...

January 2020 60 pages

Diarrhea - Pipeline Insight, 2020

US$ 2,000.00

... clients within 5 Days 'Diarrhea - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Diarrhea development. The report provides detailed ...

January 2020 60 pages

Diphtheria - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Diphtheria - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Diphtheria development. The report provides detailed ...

January 2020 60 pages

Duodenal Ulcer - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Duodenal Ulcer - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Duodenal Ulcer development. The report provides ...

January 2020 60 pages

Dyskinesia - Pipeline Insight, 2020

US$ 1,500.00

... clients within 72 Hours 'Dyskinesia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Dyskinesia development. The report provides detailed ...

January 2020 60 pages

Dyspepsia - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Dyspepsia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Dyspepsia development. The report provides detailed ...

January 2020 120 pages

Emesis (Vomiting) - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Emesis (Vomiting) - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Emesis (Vomiting) development. The report provides ...

January 2020 120 pages

Encephalopathy - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Encephalopathy - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Encephalopathy development. The report provides detailed ...

January 2020 90 pages

Eosinophilic Esophagitis - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Eosinophilic Esophagitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Eosinophilic Esophagitis development. The report provides ...

January 2020 60 pages

Epithelial Ovarian Cancer - Pipeline Insight, 2020

US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Epithelial Ovarian Cancer The report also ...

January 2020 60 pages

Erectile Dysfunction - Pipeline Insight, 2020

US$ 1,500.00

... clients within 72 Hours 'Erectile Dysfunction - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Erectile Dysfunction development. The report provides ...

January 2020 60 pages

Fabry Disease - Pipeline Insight, 2020

US$ 1,500.00

... clients within 72 Hours 'Fabry Disease - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Fabry Disease development. The report provides ...

January 2020 60 pages

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) The report also ...

January 2020 60 pages

Familial Chylomicronemia (Type I Hyperlipoproteinemia) - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Familial Chylomicronemia (Type I Hyperlipoproteinemia) The report also covers ...

January 2020 60 pages

Familial Hypercholesterolemia (Type II Hyperlipoproteinemia - Pipeline Insight, 2020

US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Familial Hypercholesterolemia (Type II Hyperlipoproteinemia The report also covers ...

January 2020 60 pages

Fatigue - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Fatigue - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Fatigue development. The report provides detailed ...

January 2020 60 pages

Febrile Neutropenia - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Febrile Neutropenia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Febrile Neutropenia development. The report provides ...

January 2020 60 pages

Fecal Incontinence - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Fecal Incontinence - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Fecal Incontinence development. The report provides ...

January 2020 60 pages

Friedreich Ataxia - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Friedreich Ataxia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Friedreich Ataxia development. The report provides ...

January 2020 60 pages

Gastric Ulcers - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Gastric Ulcers - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Gastric Ulcers development. The report provides ...

January 2020 120 pages

Gastritis - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Gastritis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Gastritis development. The report provides detailed ...

January 2020 60 pages

Gingivitis - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Gingivitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Gingivitis development. The report provides detailed ...

January 2020 90 pages

Glomerulonephritis - Pipeline Insights, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Glomerulonephritis - Pipeline Insight, 2019 The report also ...

January 2020 60 pages

Gouty Arthritis (Gout) - Pipeline Insight, 2020

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Gouty Arthritis (Gout) The report also ...

January 2020 120 pages

Hairy Cell Leukemia - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Hairy Cell Leukemia The report also ...

January 2020 60 pages

Ischemic Cardiomyopathy - Pipeline Insights, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Ischemic Cardiomyopathy - Pipeline Insight, 2019 The report ...

January 2020 90 pages

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insights, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insight, 2019 The ...

January 2020 60 pages

Sarcoidosis - Pipeline Insights, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Sarcoidosis - Pipeline Insight, 2019 The report also ...

January 2020 60 pages

Tourette Syndrome - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Tourette Syndrome - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Tourette Syndrome development. The report provides ...

January 2020 120 pages

Traumatic Brain Injury(TBI) - Pipeline Insights, 2020

US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Traumatic Brain Injury(TBI) - Pipeline Insight, 2019 The ...

January 2020 60 pages

Urinary Incontinence - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Urinary Incontinence - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Urinary Incontinence development. The report provides ...

January 2020 90 pages

Urinary Tract Infections - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Urinary Tract Infections The report also ...

January 2020 90 pages

Uterine Leiomyoma (Uterine Fibroids) - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Uterine Leiomyoma (Uterine Fibroids) The report also ...

January 2020 60 pages

Filters

Search

Categories

5,477
618
651
143

Publishers

6,889

Regions

6,889

Price

Date

Pages

Offers